Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kimberly M. Thompson & Kamran Badizadegan. (2022) Health economic analyses of secondary vaccine effects: a systematic review and policy insights. Expert Review of Vaccines 21:3, pages 297-312.
Read now
Read now
James Kenneth Timmis, Steven Black & Rino Rappuoli. (2017) Improving accountability in vaccine decision-making. Expert Review of Vaccines 16:11, pages 1057-1066.
Read now
Read now
Alistair McGuire, Mike Drummond & Sam Keeping. (2016) Childhood and adolescent influenza vaccination in Europe: A review of current policies and recommendations for the future. Expert Review of Vaccines 15:5, pages 659-670.
Read now
Read now
Carla D Scarbrough Lefebvre, Augustin Terlinden & Baudouin Standaert. (2015) Dissecting the indirect effects caused by vaccines into the basic elements. Human Vaccines & Immunotherapeutics 11:9, pages 2142-2157.
Read now
Read now
Nagendra R Hegde. (2015) Cell culture-based influenza vaccines: A necessary and indispensable investment for the future. Human Vaccines & Immunotherapeutics 11:5, pages 1223-1234.
Read now
Read now
Emma Quinn, Mark Jit & Anthony T Newall. (2014) Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination. Expert Review of Pharmacoeconomics & Outcomes Research 14:3, pages 425-435.
Read now
Read now
Articles from other publishers (25)
Latefa Ali Dardas, Obada Al-leimon, Abdel Rahman Jaber, Mohammed Saadeh, Ahmad Al-leimon, Ahmad Al-Hurani, Abdul-Raheem Jaber, Omer Aziziye, Fadi Al-salieby, Mohammad Aljahalin & Brittney Van de Water. (2023) Flu Shots Unveiled: A Global Systematic Review of Healthcare Providers’ Uptake of, Perceptions, and Attitudes toward Influenza Vaccination. Vaccines 11:12, pages 1760.
Crossref
Crossref
K. E. Lafond, R. Gharpure, V. G. Dugan & E. Azziz-Baumgartner. (2023) Estimating the full health and economic benefits of current and future influenza vaccines. BMC Medicine 21:1.
Crossref
Crossref
Camino Prada-García, Virginia Fernández-Espinilla, Cristina Hernán-García, Iván Sanz-Muñoz, José Martínez-Olmos, Jose M. Eiros & Javier Castrodeza-Sanz. (2022) Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain. International Journal of Environmental Research and Public Health 19:17, pages 11139.
Crossref
Crossref
Aniruddha Deka & Samit Bhattacharyya. (2022) The effect of human vaccination behaviour on strain competition in an infectious disease: An imitation dynamic approach. Theoretical Population Biology 143, pages 62-76.
Crossref
Crossref
Tanja Fens, Pieter T. de Boer, Eugène P. van Puijenbroek & Maarten J. Postma. (2021) Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review. Vaccines 9:2, pages 111.
Crossref
Crossref
Ijeoma Edoka, Ciaran Kohli-Lynch, Heather Fraser, Karen Hofman, Stefano Tempia, Meredith McMorrow, Wayne Ramkrishna, Philipp Lambach, Raymond Hutubessy & Cheryl Cohen. (2021) A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme. Vaccine 39:2, pages 412-422.
Crossref
Crossref
Bin-Shenq Ho & Kun-Mao Chao. (2020) On the influenza vaccination policy through mathematical modeling. International Journal of Infectious Diseases 98, pages 71-79.
Crossref
Crossref
Ioannis Dardalas, Chryssa Pourzitaki, Georgios Manomenidis, Faye Malliou, Petros Galanis, Georgios Papazisis, Dimitrios Kouvelas & Thalia Bellali. (2019) Predictors of influenza vaccination among elderly: a cross-sectional survey in Greece. Aging Clinical and Experimental Research 32:9, pages 1821-1828.
Crossref
Crossref
Shinya Tsuzuki, Marc Baguelin, Richard Pebody & Edwin van Leeuwen. (2020) Modelling the optimal target age group for seasonal influenza vaccination in Japan. Vaccine 38:4, pages 752-762.
Crossref
Crossref
Michelle L. Giles, Pauline Paterson, Flor M. Munoz, Heidi Larson & Philipp Lambach. 2020. Maternal Immunization. Maternal Immunization
87
111
.
Dabeyva Chavez, Vicente Gonzales‐Armayo, Elvis Mendoza, Rakhee Palekar, Rosario Rivera, Angel Rodriguez, Claudia Salazar, Angel Veizaga & Arletta Añez. (2019) Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data—La Paz, Bolivia. 2012–2017. Influenza and Other Respiratory Viruses 13:5, pages 477-483.
Crossref
Crossref
Suresh Mahendra Raj, Abrar Ahmad Chughtai, Anurag Sharma, Timothy C. Tan & C. Raina MacIntyre. (2019) Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50–64 years old. Vaccine 37:40, pages 5979-5985.
Crossref
Crossref
Zandile Mhlwatika & Blessing Aderibigbe. (2018) Application of Dendrimers for the Treatment of Infectious Diseases. Molecules 23:9, pages 2205.
Crossref
Crossref
Mitchell P. Somes, Robin M. Turner, Liam J. Dwyer & Anthony T. Newall. (2018) Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis. Vaccine 36:23, pages 3199-3207.
Crossref
Crossref
Anthony T. Newall, Nathorn Chaiyakunapruk, Philipp Lambach & Raymond C. W. Hutubessy. (2018) WHO guide on the economic evaluation of influenza vaccination. Influenza and Other Respiratory Viruses 12:2, pages 211-219.
Crossref
Crossref
Viviana Sotomayor, Rodrigo A. Fasce, Natalia Vergara, Felipe De la Fuente, Sergio Loayza & Rakhee Palekar. (2018) Estimating the burden of influenza-associated hospitalizations and deaths in Chile during 2012-2014. Influenza and Other Respiratory Viruses 12:1, pages 138-145.
Crossref
Crossref
Sankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, Betina T. Blak, Yanli Zhao, Judith Hackett, Robert Brody, Vishal Patel & Billy Amzal. (2017) Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach. PLOS ONE 12:12, pages e0186739.
Crossref
Crossref
Gemma E Shields, Jamie Elvidge & Linda M Davies. (2017) A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union. BMJ Open 7:6, pages e014847.
Crossref
Crossref
Eva van Doorn, Maryam Darvishian, Frederika Dijkstra, Gé A. Donker, Pieter Overduin, Adam Meijer & Eelko Hak. (2017) Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups. Vaccine 35:21, pages 2831-2839.
Crossref
Crossref
Robin Kobbe. (2015) The ESPID/ESWI Joint Symposium—A strong vote for universal influenza vaccination in children in Europe. Vaccine 33:49, pages 6967-6969.
Crossref
Crossref
Mark Jit. (2015) High-dose influenza vaccines make economic sense for older people. The Lancet Infectious Diseases 15:12, pages 1372-1373.
Crossref
Crossref
Aronrag Meeyai, Naiyana Praditsitthikorn, Surachai Kotirum, Wantanee Kulpeng, Weerasak Putthasri, Ben S. Cooper & Yot Teerawattananon. (2015) Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis. PLOS Medicine 12:5, pages e1001829.
Crossref
Crossref
Adriaan Blommaert, Joke Bilcke, Yannick Vandendijck, Germaine Hanquet, Niel Hens & Philippe Beutels. (2014) Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. Vaccine 32:46, pages 6075-6083.
Crossref
Crossref
Joke Bilcke, Samuel Coenen & Philippe Beutels. (2014) Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All. PLoS ONE 9:7, pages e102634.
Crossref
Crossref
Yanyu Xiao & Seyed M Moghadas. (2013) Impact of viral drift on vaccination dynamics and patterns of seasonal influenza. BMC Infectious Diseases 13:1.
Crossref
Crossref